Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) has announced the receipt of trading approval for 35,35,51,410 fully paid-up Equity shares. These shares were allotted as part of a Scheme of Amalgamation. The shares are listed and admitted to dealings on both the National Stock Exchange of India Limited and BSE Limited, becoming available for trading from Monday, August 17, 2026.
Trading Approval Secured for Amalgamation Shares
Aster DM Quality Care Limited, formerly known as Aster DM Healthcare Limited, has officially received trading approval for a substantial block of 35,35,51,410 equity shares. These shares, each with a face value of ₹10, have been allotted in full pursuant to the company’s Scheme of Amalgamation.
Listing and Trading Commencement
The approval for trading was granted by both the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on August 14, 2026. Consequently, these newly allotted equity shares will be officially listed and available for trading on both exchanges starting from Monday, August 17, 2026.
Scheme of Amalgamation Details
This allotment follows a previously intimated letter dated July 13, 2026, which confirmed the allotment to eligible shareholders of the Transferor Company as of the Record Date, Thursday, July 9, 2026. The Scheme of Amalgamation involved Quality Care India Limited (the Transferor Company) and Aster DM Healthcare Limited (the Transferee Company).
Disclosure and Further Information
The company has also uploaded this intimation on its official website, www.asterqualitycare.com. The distinct numbers for these equity shares range from 523835315 to 877386724.
Source: BSE
